Expertise in
8
conditions

Dr. Anna Bruckner

Pediatrics
Children's Hospital Colorado
13123 E 16th Ave, 
Aurora, CO 
Expertise in
8
conditions
Children's Hospital Colorado
13123 E 16th Ave, 
Aurora, CO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Anna Bruckner is a Pediatrics provider in Aurora, Colorado. Dr. Bruckner is highly rated in 8 conditions, according to our data. Her top areas of expertise are Epidermolysis Bullosa, Dystrophic Epidermolysis Bullosa, Dominant Dystrophic Epidermolysis Bullosa, and Dowling-Meara Epidermolysis Bullosa Simplex.

Her clinical research consists of co-authoring 77 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatrics
Licenses
Dermatology in CO
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Denver Health Medical Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Rocky Mountain Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Sunflower Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 14 Less Insurance Carriers -

Locations

Children's Hospital Colorado
13123 E 16th Ave, Aurora, CO 80045
Call: 720-777-8445
Other Locations
Children's Hospital Colorado
1811 Plaza Dr, Highlands Ranch, CO 80129
Call: 720-478-1234

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

Phase 2 Multi Center Prospective Rand. Double Blind Placebo Cont. Parallel Design Study to Evaluate Safety & Efficacy of Topical Sirolimus for Cutaneous Angiofibromas in Subjects W/ Tuberous Sclerosis Complex Followed by Opt. Open Label
Phase 2 Multi Center Prospective Rand. Double Blind Placebo Cont. Parallel Design Study to Evaluate Safety & Efficacy of Topical Sirolimus for Cutaneous Angiofibromas in Subjects W/ Tuberous Sclerosis Complex Followed by Opt. Open Label
Enrollment Status: Terminated
Publish Date: December 01, 2025
Intervention Type: Drug
Study Drug: Sirolimus
Study Phase: Phase 2
Use of Otoscope as a Non-invasive Tool for Diagnosis of Pilomatricoma
Use of Otoscope as a Non-invasive Tool for Diagnosis of Pilomatricoma
Enrollment Status: Completed
Publish Date: December 27, 2024
A Pivotal Phase 3 Study of FCX-007 (Genetically-Modified Autologous Human Dermal Fibroblasts) for Recessive Dystrophic Epidermolysis Bullosa
A Pivotal Phase 3 Study of FCX-007 (Genetically-Modified Autologous Human Dermal Fibroblasts) for Recessive Dystrophic Epidermolysis Bullosa
Enrollment Status: Active_not_recruiting
Publish Date: April 01, 2024
Intervention Type: Biological
Study Drug: FCX-007 (Dabocemagene Autoficel)
Study Phase: Phase 3
Double-blind, Randomised, Vehicle-controlled, Phase III, Efficacy and Safety Study With 24-month Open-label Follow-up of Oleogel-S10 in Patients With Inherited Epidermolysis Bullosa
Double-blind, Randomised, Vehicle-controlled, Phase III, Efficacy and Safety Study With 24-month Open-label Follow-up of Oleogel-S10 in Patients With Inherited Epidermolysis Bullosa
Enrollment Status: Completed
Publish Date: July 20, 2023
Intervention Type: Drug
Study Drug: Oleogel-S10
Study Phase: Phase 3
A Phase I/II Study of FCX-007 (Genetically-Modified Autologous Human Dermal Fibroblasts) for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
A Phase I/II Study of FCX-007 (Genetically-Modified Autologous Human Dermal Fibroblasts) for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Enrollment Status: Terminated
Publish Date: February 08, 2023
Intervention Type: Genetic
Study Phase: Phase 1/Phase 2
Phase 2 Study of Sildenafil for the Treatment of Lymphatic Malformations
Phase 2 Study of Sildenafil for the Treatment of Lymphatic Malformations
Enrollment Status: Completed
Publish Date: November 17, 2022
Intervention Type: Drug, Other
Study Drug: Sildenafil
Study Phase: Phase 2
Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis
Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: September 27, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2 Open-Label Study of PTR-01 in Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
A Phase 2 Open-Label Study of PTR-01 in Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Enrollment Status: Completed
Publish Date: September 16, 2021
Intervention Type: Drug
Study Drug: PTR-01
Study Phase: Phase 2
A First in Human, Double-blind, Randomized, Intra-subject Placebo-controlled, Multiple Dose Study of QR-313 Evaluating Safety, Proof of Mechanism, Preliminary Efficacy and Systemic Exposure in Subjects With DDEB or RDEB Due to Mutation(s) in Exon 73 of the COL7A1 Gene
A First in Human, Double-blind, Randomized, Intra-subject Placebo-controlled, Multiple Dose Study of QR-313 Evaluating Safety, Proof of Mechanism, Preliminary Efficacy and Systemic Exposure in Subjects With DDEB or RDEB Due to Mutation(s) in Exon 73 of the COL7A1 Gene
Enrollment Status: Terminated
Publish Date: August 25, 2021
Intervention Type: Drug
Study Drug: QR-313
Study Phase: Phase 1/Phase 2
A Phase 1/2 Randomized, Saline-Controlled, Single-Blind, Multiple Ascending Dose, Dose-Escalation, Multi-Center Trial of PTR-01 in Adult Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
A Phase 1/2 Randomized, Saline-Controlled, Single-Blind, Multiple Ascending Dose, Dose-Escalation, Multi-Center Trial of PTR-01 in Adult Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Enrollment Status: Completed
Publish Date: March 09, 2021
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Phase 3, Multi-center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of SD-101 Cream in Patients With Epidermolysis Bullosa
A Phase 3, Multi-center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of SD-101 Cream in Patients With Epidermolysis Bullosa
Enrollment Status: Completed
Publish Date: April 09, 2020
Intervention Type: Drug
Study Phase: Phase 3
An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex
An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex
Enrollment Status: Terminated
Publish Date: November 05, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 11 Less Clinical Trials

77 Total Publications

Methodological Concerns in the EASE Study of Oleogel-S10 for Epidermolysis Bullosa: reply from authors.
Methodological Concerns in the EASE Study of Oleogel-S10 for Epidermolysis Bullosa: reply from authors.
Journal: The British journal of dermatology
Published: September 10, 2025
View All 77 Publications
Similar Doctors
David Norris
Expertise in
13
conditions
Dr. David Norris
Dermatology
Expertise in
13
conditions
Dr. David Norris
Dermatology

University Of Colorado Hospital

1665 Aurora Ct, 
Aurora, CO 
 (0.2 miles away)
720-848-0500
Languages Spoken:
English
See accepted insurances

David Norris is a Dermatologist in Aurora, Colorado. Dr. Norris is highly rated in 13 conditions, according to our data. His top areas of expertise are Alopecia Areata, Autosomal Recessive Hypotrichosis, Eosinophilic Fasciitis, and Female Pattern Baldness.

Expertise in
13
conditions
Dr. Theresa R. Pacheco
Dermatology
Expertise in
13
conditions
Dr. Theresa R. Pacheco
Dermatology

University Physicians Incorporated

13123 E 16th Ave, 
Aurora, CO 
 (0.1 miles away)
720-777-1234
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Theresa Pacheco is a Dermatologist in Aurora, Colorado. Dr. Pacheco is highly rated in 13 conditions, according to our data. Her top areas of expertise are Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, T-Cell Lymphoma, and Lymphomatoid Papulosis. Dr. Pacheco is currently accepting new patients.

Expertise in
10
conditions
Dr. Mariah R. Brown
Dermatology | Pediatrics
Expertise in
10
conditions
Dr. Mariah R. Brown
Dermatology | Pediatrics

Dawson Dermatology Group PLLC

499 E Hampden Ave, Suite 390, 
Englewood, CO 
 (9.9 miles away)
303-390-0795
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Mariah Brown is a Dermatologist and a Pediatrics provider in Englewood, Colorado. Dr. Brown is highly rated in 10 conditions, according to our data. Her top areas of expertise are Basal Cell Skin Cancer, Melanoma, Squamous Cell Skin Carcinoma, and Bowen's Disease. Dr. Brown is currently accepting new patients.

VIEW MORE Pediatricians

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bruckner's expertise for a condition
ConditionClose
  • Elite
  • Dystrophic Epidermolysis Bullosa
    Dr. Bruckner is
    Elite
    . Learn about Dystrophic Epidermolysis Bullosa.
    See more Dystrophic Epidermolysis Bullosa experts
  • Epidermolysis Bullosa
    Dr. Bruckner is
    Elite
    . Learn about Epidermolysis Bullosa.
    See more Epidermolysis Bullosa experts
  • Distinguished
  • Dominant Dystrophic Epidermolysis Bullosa
    Dr. Bruckner is
    Distinguished
    . Learn about Dominant Dystrophic Epidermolysis Bullosa.
    See more Dominant Dystrophic Epidermolysis Bullosa experts
  • Dowling-Meara Epidermolysis Bullosa Simplex
    Dr. Bruckner is
    Distinguished
    . Learn about Dowling-Meara Epidermolysis Bullosa Simplex.
    See more Dowling-Meara Epidermolysis Bullosa Simplex experts
  • Advanced
  • Bullae
    Dr. Bruckner is
    Advanced
    . Learn about Bullae.
    See more Bullae experts
  • Epidermolysis Bullosa Simplex
    Dr. Bruckner is
    Advanced
    . Learn about Epidermolysis Bullosa Simplex.
    See more Epidermolysis Bullosa Simplex experts
  • Lamellar Ichthyosis
    Dr. Bruckner is
    Advanced
    . Learn about Lamellar Ichthyosis.
    See more Lamellar Ichthyosis experts
  • Nonbullous Congenital Ichthyosiform Erythroderma
    Dr. Bruckner is
    Advanced
    . Learn about Nonbullous Congenital Ichthyosiform Erythroderma.
    See more Nonbullous Congenital Ichthyosiform Erythroderma experts
  • Experienced
  • Acne
    Dr. Bruckner is
    Experienced
    . Learn about Acne.
    See more Acne experts
  • Akesson Syndrome
    Dr. Bruckner is
    Experienced
    . Learn about Akesson Syndrome.
    See more Akesson Syndrome experts
  • Alopecia Universalis
    Dr. Bruckner is
    Experienced
    . Learn about Alopecia Universalis.
    See more Alopecia Universalis experts
  • Aplasia Cutis Congenita
    Dr. Bruckner is
    Experienced
    . Learn about Aplasia Cutis Congenita.
    See more Aplasia Cutis Congenita experts
  • Atopic Dermatitis
    Dr. Bruckner is
    Experienced
    . Learn about Atopic Dermatitis.
    See more Atopic Dermatitis experts
  • Autosomal Recessive Hypotrichosis
    Dr. Bruckner is
    Experienced
    . Learn about Autosomal Recessive Hypotrichosis.
    See more Autosomal Recessive Hypotrichosis experts
View All 36 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
  1. Homepage
  2. Pediatricians Aurora, CO
  3. Dr. Anna Bruckner
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.